KIMBERLY OTT: Open Payments
NPI 1023602141 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,152 in 97 payments from 31 companies in 2025. Trend: 2023 $998 · 2024 $799 · 2025 $2,152
Food & beverage: $2,152
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 14 | $306 |
| Daiichi Sankyo Inc. | 7 | $189 |
| PFIZER INC. | 9 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $125 |
| E.R. Squibb & Sons, L.L.C. | 5 | $113 |
| Janssen Biotech, Inc. | 5 | $102 |
| Novartis Pharmaceuticals Corporation | 5 | $101 |
| Geron Corporation | 4 | $99 |
| Celgene Corporation | 3 | $94 |
| ABBVIE INC. | 3 | $80 |
Products named: KEYTRUDA, Enhertu, OPDIVO, RYTELO, LYNPARZA, Lenvima, NINLARO, REBLOZYL.
Industry payments across FL — which companies pay providers there.
